- €1.86bn
- €1.86bn
- €180.74m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 58.4 | 79.5 | 121 | 155 | 181 |
Cost of Revenue | |||||
Gross Profit | 51.5 | 70.4 | 106 | 139 | 169 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 58.2 | 62.4 | 92.3 | 118 | 133 |
Operating Profit | 0.219 | 17 | 28.8 | 36.9 | 47.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.117 | 16.4 | 29.3 | 37.6 | 44.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.352 | 12.8 | 22.4 | 34.3 | 35.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.352 | 12.8 | 22.4 | 34.3 | 35.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.352 | 12.8 | 22.4 | 34.3 | 35.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.015 | 0.51 | 0.879 | 1.36 | 1.39 |
Dividends per Share |